Literature DB >> 11180204

Clenbuterol reduces soleus muscle fatigue during disuse in aged rats.

K D Chen1, S E Alway.   

Abstract

High levels of clenbuterol have been shown to preserve muscle mass and function during disuse. In this study we report that a low dose of clenbuterol (10 microg/kg per day) lessened the loss of in situ soleus muscle isometric force normalized to wet muscle weight (P(o)/g wet weight) by 8% and reduced isometric fatigue by approximately 30% in senescent rats after 21 days of hindlimb suspension (HS). Clenbuterol did not reduce the loss of relative force in the soleus of adult rats or the plantaris of old or adult rats. Furthermore, clenbuterol failed to improve muscle force or isometric fatigue in the soleus of adult rats or in the plantaris of either age group after HS. We conclude that low levels of clenbuterol reduce muscle fatigue in slow muscles during disuse and this beta-agonist may also have therapeutic value for reducing fatigue in slow muscles (e.g., postural muscles) in the elderly during disuse.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180204     DOI: 10.1002/1097-4598(200102)24:2<211::aid-mus60>3.0.co;2-d

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  Age-dependent increase in oxidative stress in gastrocnemius muscle with unloading.

Authors:  Parco M Siu; Emidio E Pistilli; Stephen E Alway
Journal:  J Appl Physiol (1985)       Date:  2008-09-18

2.  Death receptor-associated pro-apoptotic signaling in aged skeletal muscle.

Authors:  Emidio E Pistilli; Janna R Jackson; Stephen E Alway
Journal:  Apoptosis       Date:  2006-12       Impact factor: 4.677

3.  Effects of hindlimb suspension and reloading on gastrocnemius and soleus muscle mass and function in geriatric mice.

Authors:  João Ricardhis S Oliveira; Junaith S Mohamed; Matthew J Myers; Matthew J Brooks; Stephen E Alway
Journal:  Exp Gerontol       Date:  2018-11-16       Impact factor: 4.032

4.  Molecular regulation of apoptosis in fast plantaris muscles of aged rats.

Authors:  Emidio E Pistilli; Parco M Siu; Stephen E Alway
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-03       Impact factor: 6.053

5.  Increased myogenic repressor Id mRNA and protein levels in hindlimb muscles of aged rats.

Authors:  Stephen E Alway; Hans Degens; Dawn A Lowe; Gururaj Krishnamurthy
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-02       Impact factor: 3.619

6.  Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice.

Authors:  Janna R Jackson; Michael J Ryan; Stephen E Alway
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-03-31       Impact factor: 6.053

7.  Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.

Authors:  G Py; C Ramonatxo; P Sirvent; A M J Sanchez; A G Philippe; A Douillard; O Galbès; C Lionne; A Bonnieu; A Chopard; O Cazorla; A Lacampagne; R B Candau
Journal:  J Physiol       Date:  2015-02-27       Impact factor: 5.182

8.  Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles.

Authors:  Jatin G Burniston; William A Clark; Lip-Bun Tan; David F Goldspink
Journal:  Muscle Nerve       Date:  2006-05       Impact factor: 3.217

9.  Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals.

Authors:  Richard T Hinkle; Frank R Lefever; Elizabeth T Dolan; Deborah L Reichart; Janice M Zwolshen; Timothy P Oneill; Kris G Maloney; John P Mattson; Leonardo F Ferreira; Timothy I Musch; David C Poole; Robert J Isfort
Journal:  BMC Musculoskelet Disord       Date:  2011-01-14       Impact factor: 2.362

10.  Effects of resveratrol on the recovery of muscle mass following disuse in the plantaris muscle of aged rats.

Authors:  Brian T Bennett; Junaith S Mohamed; Stephen E Alway
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.